Home NDC 0093-7768 Everolimus
Product NDC 0093-7768
11-digit product format 000937768
Labeler code 0093
Product ID 0093-7768_fcac6d18-baba-4f1c-b765-ff3077758ec3
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Everolimus
Dosage form TABLET
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application ANDA210050
Marketing category ANDA
Marketing start 2020-06-10
Marketing end 0000-00-00
Substance EVEROLIMUS
Active strength 8 mg/1
Pharmacologic classes Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A210050-001 EVEROLIMUS EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 A210050-002 EVEROLIMUS EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 A210050-003 EVEROLIMUS EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 A210050-004 EVEROLIMUS EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 c2088c7a36db…2026-10-15 13:18:30 2026-09 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 c2088c7a36db…2026-09-14 22:38:34 2026-08 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 84e616aacf4f…2026-09-14 22:38:34 2026-08 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 84e616aacf4f…2026-08-18 06:07:40 2026-07 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210050-001 EVEROLIMUS 2.5MG TABLET / ORAL AB 2019-12-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210050-002 EVEROLIMUS 5MG TABLET / ORAL AB 2019-12-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210050-003 EVEROLIMUS 7.5MG TABLET / ORAL AB 2019-12-09 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210050-004 EVEROLIMUS 10MG TABLET / ORAL AB 2019-12-09 2680178bc6a6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 149 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0093-7768-19 Everolimus 1 in 1 BLISTER PACK TABLET 1 10 0093-7768-24 Everolimus 28 in 1 CARTON TABLET 28 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0093-7768 EVEROLIMUS TABLET [TEVA PHARMACEUTICALS USA, INC.] 8 Legacy NDC, 2 package rows 20250216_e3bca36b-29ed-4a2b-a1be-a57b6af805f6.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0093-7768-19 00093776819 1 in 1 BLISTER PACK Historical 0093-7768-24 00093776824 28 BLISTER PACK in 1 CARTON (0093-7768-24) > 1 TABLET in 1 BLISTER PACK (0093-7768-19) 28 blister pack 2020-06-10 0000-00-00 No No Current